Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Arnold, S. E.
Right arrow Articles by Van Hoesen, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnold, S. E.
Right arrow Articles by Van Hoesen, G. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Cerebral Cortex 1991; 1:103-116
© Oxford University Press 1991


research-article

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

Steven E. Arnold1, Bradley T. Hyman1, Jill Flory2, Antonio R. Damasio1 and Gary W. Van Hoesen1,2,

1Departments of Neurology Iowa City, Iowa 52242, 2Anatomy University of Iowa College of Medicine Iowa City, Iowa 52242

Correspondence should be addressed to Dr. Gary W. Van Hoesen, Department of Anatomy, Bowen Science Building, University of Iowa, Iowa City, IA 52242.

The distribution of neurofibrillary tangles (NFTs) and neuritic plaques (NPs) was mapped in 39 cortical areas of 11 brains of patients with Alzheimer's disease (AD). Whole hemisphere blocks were embedded in polyethylene glycol (Carbowax), sectioned coronally, and stained with thioflavin S and thionin. The densities of NFTs and NPs were assessed using a numerical rating scale for each area. Scores were grouped by type of cortex and by lobe for statistical analysis. Highly significant differences were ohtained. For example, limbic periallocor tex and allocortex had more NFTs than any other type of cortex. In descending order, the density of NFTs was as follows: penallocortex (area 28) > allocortex (suhiculum/CA1 zones of hippocampal formation, area 51) > corticoid areas (accessory basal nucleus of amygdala, nucleus hasalis of Meynert) > proisocortex (areas 11, 12, 24, 23, anterior insula, 38, 35) > nonprimary association cortex (32, 46, superior temporal sulcus, 40, 39, posterior parahippocampal cortex, 37, 36) > pri mary sensory association cortex (7, 18, 19, 22, 21, 20) > agranular cortex (44–5, 8, 6, 4) > primary sensory cortex (41–2, 3–1–2, 17). The laminar distribution of NFTs tended to be selective, involving primarily layers III and V of association areas and layers II and IV of limbic periallocortex. There were far more NFTs in both limbic and temporal lobes than in frontal, panetal, and occipital lobes. In general, NPs were more evenly dis tributed throughout the cortex, with the exceptions of limbic periallocortex and allocortex, which had notably fewer NPs than other cortical areas. Temporal and oc cipital lobes had the highest NP densities, limbic and frontal lobes had the lowest, and panetal lobe was intermediate. No significant left-right hemispheric dif ferences for NFT or NP densities were found across the population, and there was no relationship between du ration of illness and densities of NFTs or NPs.

The regional and laminar distribution of NFTs (and, to a lesser degree, that of NPs) suggests a consistent pattern of vulnerability within the cerebral cortices that seems correlated to the hierarchies of cortico-cortical connections. The higher-order association cortices, es pecially those in the anterior and ventromedial sectors of temporal lobe, are the most vulnerable, while other cortices appear less vulnerable to a degree commen surate with their connectional "distance" (i.e., synapses removed) from the limbic areas.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
W. E. Klunk
Biopsy Support for the Validity of Pittsburgh Compound B Positron Emission Tomography With a Twist
Arch Neurol, October 1, 2008; 65(10): 1281 - 1283.
[Full Text] [PDF]


Home page
Cereb CortexHome page
B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco, D. N. Greve, F. Grodstein, C. I. Wright, D. Blacker, H. D. Rosas, et al.
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Cereb Cortex, July 16, 2008; (2008) bhn113v1.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
J. J. Jalbert, L. A. Daiello, and K. L. Lapane
Dementia of the Alzheimer Type
Epidemiol. Rev., July 16, 2008; (2008) mxn008v1.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Mapstone, K. Dickerson, and C. J. Duffy
Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease
Brain, June 1, 2008; 131(6): 1618 - 1629.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
S. Wiederkehr, M. Simard, C. Fortin, and R. van Reekum
Comparability of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part I
J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 150 - 161.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
P. Koenig, E. E. Smith, V. Troiani, C. Anderson, P. Moore, and M. Grossman
Medial Temporal Lobe Involvement in an Implicit Memory Task: Evidence of Collaborating Implicit and Explicit Memory Systems from fMRI and Alzheimer's Disease
Cereb Cortex, April 9, 2008; (2008) bhn043v1.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. R. Jack Jr, V. J. Lowe, M. L. Senjem, S. D. Weigand, B. J. Kemp, M. M. Shiung, D. S. Knopman, B. F. Boeve, W. E. Klunk, C. A. Mathis, et al.
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
Brain, March 1, 2008; 131(3): 665 - 680.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Bentley, J. Driver, and R. J. Dolan
Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health
Brain, February 1, 2008; 131(2): 409 - 424.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
G.D. Rabinovici, W.W. Seeley, E.J. Kim, M.L. Gorno-Tempini, K. Rascovsky, T.A. Pagliaro, S.C. Allison, C. Halabi, J.H. Kramer, J.K. Johnson, et al.
Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 474 - 488.
[Abstract] [PDF]


Home page
StrokeHome page
L. L. Beason-Held, A. Moghekar, A. B. Zonderman, M. A. Kraut, and S. M. Resnick
Longitudinal Changes in Cerebral Blood Flow in the Older Hypertensive Brain
Stroke, June 1, 2007; 38(6): 1766 - 1773.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. D. Rabinovici, A. J. Furst, J. P. O'Neil, C. A. Racine, E. C. Mormino, S. L. Baker, S. Chetty, P. Patel, T. A. Pagliaro, W. E. Klunk, et al.
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Neurology, April 10, 2007; 68(15): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Ng, V. L. Villemagne, S. Berlangieri, S.-T. Lee, M. Cherk, S. J. Gong, U. Ackermann, T. Saunder, H. Tochon-Danguy, G. Jones, et al.
Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
J. Nucl. Med., April 1, 2007; 48(4): 547 - 552.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Kudo, N. Okamura, S. Furumoto, M. Tashiro, K. Furukawa, M. Maruyama, M. Itoh, R. Iwata, K. Yanai, and H. Arai
2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients
J. Nucl. Med., April 1, 2007; 48(4): 553 - 561.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. S. Forman, E. J. Mufson, S. Leurgans, D. Pratico, S. Joyce, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski
Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Neurology, March 6, 2007; 68(10): 757 - 763.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. J. Golob, R. Irimajiri, and A. Starr
Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia
Brain, March 1, 2007; 130(3): 740 - 752.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. G. Csernansky, H. Dong, A. M. Fagan, L. Wang, C. Xiong, D. M. Holtzman, and J. C. Morris
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Am J Psychiatry, December 1, 2006; 163(12): 2164 - 2169.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Mapstone, D. Logan, and C. J. Duffy
Cue integration for the perception and control of self-movement in ageing and Alzheimer's disease.
Brain, November 1, 2006; 129(Pt 11): 2931 - 2944.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. G. Apostolova, I. D. Dinov, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease
Brain, November 1, 2006; 129(11): 2867 - 2873.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. R. Reynolds, J. F. Reyes, Y. Fu, E. H. Bigio, A. L. Guillozet-Bongaarts, R. W. Berry, and L. I. Binder
Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.
J. Neurosci., October 18, 2006; 26(42): 10636 - 10645.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Ramani, J. H. Jensen, and J. A. Helpern
Quantitative MR Imaging in Alzheimer Disease
Radiology, October 1, 2006; 241(1): 26 - 44.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. G. Apostolova, R. A. Dutton, I. D. Dinov, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson
Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps
Arch Neurol, May 1, 2006; 63(5): 693 - 699.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. L. Spires, J. D. Orne, K. SantaCruz, R. Pitstick, G. A. Carlson, K. H. Ashe, and B. T. Hyman
Region-specific Dissociation of Neuronal Loss and Neurofibrillary Pathology in a Mouse Model of Tauopathy
Am. J. Pathol., May 1, 2006; 168(5): 1598 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, and H. Braak
The Development of Amyloid beta Protein Deposits in the Aged Brain
Sci. Aging Knowl. Environ., March 8, 2006; 2006(6): re1 - re1.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. Holtzer, M. C. Irizarry, J. Sanders, B. T. Hyman, D. J. Wegesin, A. Riba, J. Brandt, M. Albert, and Y. Stern
Relation of Quantitative Indexes of Concurrent {alpha}-Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease
Arch Neurol, February 1, 2006; 63(2): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. E. Perez, O. Lazarov, J. B. Koprich, E.-Y. Chen, V. Rodriguez-Menendez, J. W. Lipton, S. S. Sisodia, and E. J. Mufson
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice
J. Neurosci., November 2, 2005; 25(44): 10220 - 10229.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. T. Francis
Neuroanatomy/pathology and the interplay of neurotransmitters in moderate to severe Alzheimer disease
Neurology, September 27, 2005; 65(6_suppl_3): S5 - S9.
[Full Text]


Home page
NeurologyHome page
D. Mungas, D. Harvey, B. R. Reed, W. J. Jagust, C. DeCarli, L. Beckett, W. J. Mack, J. H. Kramer, M. W. Weiner, N. Schuff, et al.
Longitudinal volumetric MRI change and rate of cognitive decline
Neurology, August 23, 2005; 65(4): 565 - 571.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. M. Dannhauser, Z. Walker, T. Stevens, L. Lee, M. Seal, and S. S. Shergill
The functional anatomy of divided attention in amnestic mild cognitive impairment
Brain, June 1, 2005; 128(6): 1418 - 1427.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Golby, G. Silverberg, E. Race, S. Gabrieli, J. O'Shea, K. Knierim, G. Stebbins, and J. Gabrieli
Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory
Brain, April 1, 2005; 128(4): 773 - 787.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
N. P.L.G. Verhoeff, A. A. Wilson, S. Takeshita, L. Trop, D. Hussey, K. Singh, H. F. Kung, M.-P. Kung, and S. Houle
In-Vivo Imaging of Alzheimer Disease {beta}-Amyloid With [11C]SB-13 PET
Am J Geriatr Psychiatry, December 1, 2004; 12(6): 584 - 595.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. E. Koliatsos, T. M. Dawson, A. Kecojevic, Y. Zhou, Y.-F. Wang, and K.-X. Huang
Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons
PNAS, September 28, 2004; 101(39): 14264 - 14269.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
D. R. Thal, K. Del Tredici, and H. Braak
Neurodegeneration in Normal Brain Aging and Disease
Sci. Aging Knowl. Environ., June 9, 2004; 2004(23): pe26 - pe26.
[Abstract] [Full Text]


Home page
AJGPHome page
N. Nishioka and S. E. Arnold
Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia
Am J Geriatr Psychiatry, April 1, 2004; 12(2): 167 - 175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. T. Wong, D. Manfra, F. M. Poulet, Q. Zhang, H. Josien, T. Bara, L. Engstrom, M. Pinzon-Ortiz, J. S. Fine, H.-J. J. Lee, et al.
Chronic Treatment with the {gamma}-Secretase Inhibitor LY-411,575 Inhibits {beta}-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation
J. Biol. Chem., March 26, 2004; 279(13): 12876 - 12882.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Ingelsson, H. Fukumoto, K. L. Newell, J. H. Growdon, E. T. Hedley-Whyte, M. P. Frosch, M. S. Albert, B. T. Hyman, and M. C. Irizarry
Early A{beta} accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Neurology, March 23, 2004; 62(6): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Grossman, C. McMillan, P. Moore, L. Ding, G. Glosser, M. Work, and J. Gee
What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration
Brain, March 1, 2004; 127(3): 628 - 649.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. I. Miller, M. Hosakere, A. R. Barker, C. E. Priebe, N. Lee, J. T. Ratnanather, L. Wang, M. Gado, J. C. Morris, and J. G. Csernansky
Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging
PNAS, December 9, 2003; 100(25): 15172 - 15177.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Mousseau, S. Chapelsky, G. De Crescenzo, M. D. Kirkitadze, J. Magoon, S. Inoue, D. B. Teplow, and M. D. O'Connor-McCourt
A Direct Interaction between Transforming Growth Factor (TGF)-{beta}s and Amyloid-{beta} Protein Affects Fibrillogenesis in a TGF-{beta}Receptor-independent Manner
J. Biol. Chem., October 3, 2003; 278(40): 38715 - 38722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Falke, J. Nissanov, T. W. Mitchell, D. A. Bennett, J. Q. Trojanowski, and S. E. Arnold
Subicular Dendritic Arborization in Alzheimer's Disease Correlates with Neurofibrillary Tangle Density
Am. J. Pathol., October 1, 2003; 163(4): 1615 - 1621.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Yang, E. J. Mufson, and K. Herrup
Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease
J. Neurosci., April 1, 2003; 23(7): 2557 - 2563.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. M. Clark and J. H.T. Karlawish
Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies
Ann Intern Med, March 4, 2003; 138(5): 400 - 410.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
N. Scarmeas, E. Zarahn, K. E. Anderson, C. G. Habeck, J. Hilton, J. Flynn, K. S. Marder, K. L. Bell, H. A. Sackeim, R. L. Van Heertum, et al.
Association of Life Activities With Cerebral Blood Flow in Alzheimer Disease: Implications for the Cognitive Reserve Hypothesis
Arch Neurol, March 1, 2003; 60(3): 359 - 365.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Grossman, P. Koenig, G. Glosser, C. DeVita, P. Moore, J. Rhee, J. Detre, D. Alsop, and J. Gee
Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study
Brain, February 1, 2003; 126(2): 292 - 311.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. M. Thompson, K. M. Hayashi, G. de Zubicaray, A. L. Janke, S. E. Rose, J. Semple, D. Herman, M. S. Hong, S. S. Dittmer, D. M. Doddrell, et al.
Dynamics of Gray Matter Loss in Alzheimer's Disease
J. Neurosci., February 1, 2003; 23(3): 994 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. G. Sheng, D. L. Price, and V. E. Koliatsos
Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Abeta Amyloidosis
J. Neurosci., November 15, 2002; 22(22): 9794 - 9799.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. Fukumoto, B. S. Cheung, B. T. Hyman, and M. C. Irizarry
{beta}-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease
Arch Neurol, September 1, 2002; 59(9): 1381 - 1389.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Y. HWANG, K. R. CHAE, T. S. KANG, J. H. HWANG, C. H. LIM, H. K. KANG, J. S. GOO, M. R. LEE, H. J. LIM, S. H. MIN, et al.
Alterations in behavior, amyloid {beta}-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease
FASEB J, June 1, 2002; 16(8): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. L. Cummings and G. Cole
Alzheimer Disease
JAMA, May 8, 2002; 287(18): 2335 - 2338.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Ohnishi, H. Matsuda, T. Tabira, T. Asada, and M. Uno
Changes in Brain Morphology in Alzheimer Disease and Normal Aging: Is Alzheimer Disease an Exaggerated Aging Process?
AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1680 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Deng, M. C. Irizarry, R. M. Nitsch, J. H. Growdon, and G. W. Rebeck
Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease
Am. J. Pathol., September 1, 2001; 159(3): 1061 - 1068.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Abeta 42 Fibrils
Science, August 24, 2001; 293(5534): 1491 - 1495.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Fein, V. Di Sclafani, J. Tanabe, V. Cardenas, M. W. Weiner, W. J. Jagust, B. R. Reed, D. Norman, N. Schuff, L. Kusdra, et al.
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease
Neurology, December 12, 2000; 55(11): 1626 - 1635.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. G. Csernansky, L. Wang, S. Joshi, J. P. Miller, M. Gado, D. Kido, D. McKeel, J. C. Morris, and M. I. Miller
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus
Neurology, December 12, 2000; 55(11): 1636 - 1643.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. W. Mitchell, J. Nissanov, L.-Y. Han, E. J. Mufson, J. A. Schneider, E. J. Cochran, D. A. Bennett, V. M.-Y. Lee, J. Q. Trojanowski, and S. E. Arnold
Novel Method to Quantify Neuropil Threads in Brains from Elders With or Without Cognitive Impairment
J. Histochem. Cytochem., December 1, 2000; 48(12): 1627 - 1638.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
I. Greeve, I. Hermans-Borgmeyer, C. Brellinger, D. Kasper, T. Gomez-Isla, C. Behl, B. Levkau, and R. M. Nitsch
The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress
J. Neurosci., October 1, 2000; 20(19): 7345 - 7352.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. Jack Jr., R. C. Petersen, Y. Xu, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. G. Tangalos, and E. Kokmen
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
Neurology, August 22, 2000; 55(4): 484 - 490.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
G. W. Van Hoesen, J. Parvizi, and C.-C. Chu
Orbitofrontal Cortex Pathology in Alzheimer's Disease
Cereb Cortex, March 1, 2000; 10(3): 243 - 251.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page